Allogene Therapeutics, Inc. Common Stock (ALLO) is a publicly traded Healthcare sector company. As of July 15, 2026, ALLO trades at $1.90 with a market cap of $638.54M and a P/E ratio of -2.15. ALLO moved +3.78% today. Year to date, ALLO is +35.04%; over the trailing twelve months it is +43.41%. Its 52-week range spans $0.86 to $4.46. Analyst consensus is strong buy with an average price target of $9.09. Rallies surfaces ALLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ALLO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.90 |
| Market Cap | $638.54M |
| P/E Ratio | -2.15 |
| EPS | $-0.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.46 |
| 52-Week Low | $0.86 |
| Volume | 5.33M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-190.89M |
| Gross Margin | 0.00% |
12 analysts cover ALLO: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.09.